CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: November-15-11
Credit Expiration Date: November-15-12


Louis Kuritzky, MD
Family Physician
Clinical Assistant Professor
Dept. of Community Health and Family Medicine
University of Florida
Gainesville, FL

Credit Hours

0.5 Contact Hour (0.05 CEU)
0.5 Credit Hour


Clinical Case Challenge (Online)

Program Description

Chronic constipation, particularly in older adults, can dramatically impact quality of life and lead to serious medical problems. The estimated prevalence of chronic constipation in the U.S. is between 2% and 27%, but this rate increases to 40% among people over 65 years of age. Older adults are at particular risk due to additional chronic disease burdens, polypharmacy, immobility, and/or functional limitations.

Effective management of chronic constipation requires a combination of provider and patient education, lifestyle and/or pharmacologic modifications, and the judicious use of pharmacologic and nonpharmacologic therapies. This clinical case challenge will review approaches to treatment and outline considerations for tailoring care for patients taking multiple medications and medication-induced constipation.

Program Developer/Facilitator


Target Audience

Primary and long-term care physicians, pharmacists, physician assistants, and other health care professionals involved in the care of older adults.

Learning Objectives

Upon completion of this knowledge-based educational activity, the participant should be able to:

  1. Describe ways to modify drug regimens to reduce constipation symptoms in older adults taking multiple medications.
  2. Outline constipation management strategies for patients who are taking multiple required medications.


All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by the American Society of Consultant Pharmacists (ASCP), and AKH are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

Dr. Kuritzky discloses that he is a consultant and on the speaker's bureau for Takeda.

Additional planning committee members, Medical Communications Media, ASCP, AKH staff have the following to disclose.

Ms. Dechevalier has no relevant financial conflicts to disclose.
Dr. Gerber has no relevant financial conflicts to disclose.

Dr. Holman and AKH staff have no relevant financial conflicts to disclose.

Ms. Hines has no relevant financial conflicts to disclose.
Dr. Thier has no relevant financial conflicts to disclose.
Dr. Paczolt has no relevant financial conflicts to disclose.

Credit Statements

Pharmacy Continuing Education:
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity, ACPE Universal Activity #0203-9999-11-161-H01-P, has been assigned 0.5 Contact Hour (0.05 CEU).

Physician Continuing Medical Education: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and Medical Communications Media, Inc. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support Statements

Supported by an education grant from Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc.


Minimum System Requirements: Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7. Or, Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

  1. Please turn off all pop-up blockers to ensure access to the educational activity.
  2. Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
  3. The activity will take approximately 30 minutes to complete.
  4. After the activity has finished, click on the "Post-test" button.
  5. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen. A credit statement/certificate will be awarded for a score of 80% or better and may be printed immediately after passing the post-test.

Certificate Fee



© 2011, Medical Communications Media, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, ASCP, AKH Inc, Sucampo Pharmaceuticals, Inc., or Takeda Pharmaceuticals North America, Inc. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu